期刊文献+

不同体质量糖调节异常人群血清vaspin水平变化 被引量:3

CHANGES OF SERUM LEVELS OF VASPIN IN DIFFERENT GLUCOSE TOLERANCE AND BODY WEIGHT POPULATION
下载PDF
导出
摘要 目的研究不同糖耐量及体质量人群中血清内脏脂肪组织来源的丝氨酸蛋白酶抑制剂(vaspin)水平的变化。方法研究对象按糖调节水平分为糖调节正常组(NGR组)、糖调节受损组(IGR组)及2型糖尿病组(T2DM组)。测定各组空腹血糖(FPG)、空腹C肽(FCP)、空腹血浆胰岛素(FINS)、糖化血红蛋白(HbA1c)、胆固醇(CHO)、三酰甘油(TG)、低密度脂蛋白(LDL-C)和高密度脂蛋白(HDL-C)水平。采用ELISA法测定血清vaspin水平,并分析各组血清vaspin变化及其与各种参数的相关性。结果 T2DM组和IGR组血清vaspin水平比较差异无显著性,但均显著高于NGR组(F=22.96,q=8.74、7.92,P〈0.01);女性和肥胖者血清vaspin水平分别显著高于男性和非肥胖者(t=3.43~4.18,P〈0.05)。vaspin水平与性别、腰围、BMI、FPG、HOMA-IR、FCP、HbA1C、腰臀比、FINS、CHO、LDL-C呈正相关(r=0.178~0.436,P〈0.05),性别、BMI、FPG是影响血清vaspin水平的独立相关因素。结论血清vaspin水平升高与体质量超标或肥胖和血糖升高相关,且有性别差异。 Objective To study serum levels of vaspin in population with different glucose tolerance and weight. Methods The research subjects were divided into three groups as normal glycoregulation(NGR),impaired glycoregulation(IGR) and type-2 diabetes(T2DM) group according to their glycoregulation.FBG,FCP,FPI,HbA1c,TC,TG,HDL-C,LDL-C were detected.ELISA was used to determine the serum vaspin levels.Changes of vaspin levels in each group and their correlation with each parameter were analyzed. Results Serum vaspin levels between T2DM and IGR groups were not significantly different,but both were higher than that in NGR(F=22.96;q=8.74,7.92;P0.01);that in female or the obese were higher than that in male or the non-obese(t=3.43-4.18,P0.05).The vaspin levels were positively correlated with sex,WC,BMI,FPG,HOMA-IR,FCP,HbA1C,WHR,FINS,CHO and LDL-C(r=0.178-0.436,P0.05),and sex,BMI and FPG being independent correlation factors influencing the serum vaspin. Conclusion Elevation of serum vaspin levels is associated with high blood sugar andoverweight or obesity,and with sex differences as well.
出处 《青岛大学医学院学报》 CAS 2011年第5期431-433,共3页 Acta Academiae Medicinae Qingdao Universitatis
关键词 丝氨酸蛋白酶抑制剂 糖尿病 2型 肥胖症 serine proteinase inhibitors diabetes mellitus type 2 obesity
  • 相关文献

参考文献8

  • 1HIDA K, WADA J, EGUCHI J, et al. Visceral adipose tissue-derived serine protease inhibitor.. A unique insulin-sensitizing adipocytokine in obesity[J]. ProcNstl Acad Sci USA, 2005,102:10610-10615.
  • 2KLOTING N, BERNDT J, KRALISCH S, et al. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes[J]. Biochem Biophys Res Commun, 2005, 339 : 430-436.
  • 3周晓彬,纪新强,徐莉.医用统计学软件PPMS 1.5的组成和应用特点[J].齐鲁医学杂志,2009,24(1):29-32. 被引量:297
  • 4ATABEK M E, PIRGON O, KURTOGLU S, et al. Assessment of abnormal glucose homeostasis and insulin resistance in Turkish obese children and adolescents [J]. Diabetes Obes Metab, 2007,9 : 304-310.
  • 5MIKYUNG L, YOONSUK J, JEE-AEE I M, et al. Reduced serum vaspin concentrations in obese children following shortterm intensive lifestyle modification[J]. Clinica Chimica Acta, 2010,411:381-385.
  • 6TAN B K, HEUTLING D, CHEN J, et al. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance[J]. Diabetes, 2008,57 : 1501-1507.
  • 7GULCELIK N E, KARAKAYA J, GEDIK A, et al. Serum vaspin levels in type 2 diabetic women in relation to microvascular complications[J]. Eur J Endocrinol, 2008,160:65-70.
  • 8SEEGER J, ZIEGELMEIER M, BACHMANN A, et al. Serum levels of the adipokine vaspin in relation to metabolic and renal parameters[J]. Clin Endocrinol Metab, 2008,93 : 247-51.

二级参考文献3

共引文献296

同被引文献23

  • 1Jan Dada.一种新识别的脂肪细胞因子vaspin能改善葡萄糖耐量和胰岛素敏感性[J].中国分子心脏病学杂志,2005,5(5):752-752. 被引量:8
  • 2HIDA K, WADA J, EGUCHI J,et al. Visceral adipose tis- sue-derived serine protease inhibitor: a unique in- sulin-sensitizing adipocytokine in obesity[J]. Proc Natl A- cad Sci USA,2005,102(30):10610-10615.
  • 3KLOTING N,BERNDT J,KRALISCH S,et al. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes [J]. Biochem Biophys Res Commun, 2006, 339(1): 430-436.
  • 4K1OTING N,KOVACS P, KERN M,et al.Central vaspin ad- ministration acutely reduces food intake and has sustained blood glucose-lowering effects [J]. Diabetologia,2011,54 (7),1819-1823.
  • 5KORNER A,NEEF M, FRIEBE D, et al. Vaspin is related to gender, pubetry and deteriorating insulin sensitivity in children[J]. Int J Obes (Lond), 2011,35(4): 578-586.
  • 6FAIN JN,BUEHRER B, BAHOUTH SW, et al. Comparison of messenger RNA distribution for 60 proteins in fat cells vs the nonfat cells of human omental adipose tissue [J]. Metabolism, 2008, 57(7): 1005-1015.
  • 7NYSTROM FH, QUON MJ. Insulin signalling: metabolic pathways and mechanisms for specificity [J]. Cell Signal, 1999, 11(8): 563-574.
  • 8HU L, SUN Y,HU J.Catalpol inhibits apoptosis in hydrogen peroxide induced endothelium by activating the PI3K/Akt signaling pathway and modulating expression of Bcl-2 and Bax[J].Eur J Pharmacol,2011,628(1-3): 155 - 163.
  • 9JUNG CH , LEE WJ , HWANG JY, et al. Vaspin pro- tects vascular endothelial cells against free fatty acid-induced apoptosis through a phosphatidylinositol 3-kinase/Akt pathway [J]. Biochem Biophys Res Com- mun, 2011, 413(2): 264-269.
  • 10TAN B K, HEUTLING D, CHEN J, et al. Mefformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance [J]. Diabetes,2008, 57: 1501-1507.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部